Page last updated: 2024-12-06

n-acetylvaline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-acetylvaline is a derivative of the amino acid valine, where the amino group is acetylated. It is a naturally occurring compound found in various organisms, including humans. Research suggests that N-acetylvaline may play a role in cellular processes, potentially affecting neurotransmission, oxidative stress, and mitochondrial function. Its effects on these processes are still under investigation. Interest in N-acetylvaline stems from its potential therapeutic applications. Studies have explored its potential for treating conditions like Parkinson's disease, Alzheimer's disease, and epilepsy, although further research is needed to confirm its efficacy and safety. N-acetylvaline can be synthesized chemically through a reaction involving valine and acetic anhydride.'

N-acetylvaline: RN given refers to the (DL)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID66789
CHEBI ID21565
SCHEMBL ID132349
MeSH IDM0156434

Synonyms (43)

Synonym
einecs 221-321-4
nsc 122016
AKOS015837737
l-valine, n-acetyl-
valine, n-acetyl-, l-
A-1897
n-acetylvaline
96-81-1
n-acetyl-l-valine ,
(2s)-2-acetamido-3-methylbutanoic acid
AKOS001078320
HMS1719J05
ac-val-oh
u83p7h9hv3 ,
einecs 202-537-8
unii-u83p7h9hv3
AB01318387-02
SCHEMBL132349
acetyl-l-valine
AM82366
s-(-)-n-acetylvaline
(s)-2-acetamido-3-methylbutanoic acid
l-n-acetylvaline
CHEBI:21565
(s)-2-acetylamino-3-methylbutyric acid
n-acetyl valine
n-alpha-actetyl-l-valine (ac-l-val-oh)
W-100131
J-300293
acetylvaline
GS-3342
Z57032483
CS-W016182
DTXSID40914697
ac-val
Q27290813
NCGC00323030-01
HY-W015466
O10207
EN300-297451
TS-03593
n-acyl-valine
ac-l-val-oh
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
N-acetyl-L-amino acidAn L-amino acid having an N-acetyl substituent.
L-valine derivativeA proteinogenic amino acid derivative resulting from reaction of L-valine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-valine by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (8.70)18.7374
1990's6 (26.09)18.2507
2000's7 (30.43)29.6817
2010's8 (34.78)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.08 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (20.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (4.17%)4.05%
Observational0 (0.00%)0.25%
Other23 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]